HRS Aluglaze (544656)

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

AI Analysis

AI-generated, general educational analysis — not personal investment advice.

At ₹244, HRS Aluglaze is asking me to pay ₹470 Cr for a business earning roughly ₹5 Cr on a trailing basis. That is a P/E of 91.36, and what am I getting for that rich price? Zero sales growth and zero profit growth. Graham would call this speculation, not investment. The latest quarter does show some life: ₹26 Cr in sales and ₹5 Cr in net profit, a healthy 19% margin, and the 20.16% ROCE tells me the underlying business can deploy capital reasonably well. But one good quarter does not make a moat. With a Piotroski F-Score of 3 out of 9, the financial health signals are weak, and the absence of book value, debt/equity and promoter holding data leaves too many blind spots. As Buffett says, risk comes from not knowing what you are doing. Here, the market is pricing in perfection, yet the numbers show stagnation. The zero dividend yield means the investor needs capital appreciation alone, and at 91 times earnings with no growth, that hope rests entirely on a re-rating or a sudden acceleration in earnings. I need margin of safety. This stock has none visible. I would patiently wait on the sidelines, watch for consistent quarterly earnings, and demand a far lower price before ever considering this. Value is what you get, and right now the numbers do not support the price.

The full AI analysis, bull and bear case and key monitorables are in FairStock Pro.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer